Brind.
  1. LB Pharmaceuticals Inc is seeking institutional investment for a private placement, utilizing Leerink Partners as the placement agent, with BB Biotech as a key entity.

Leerink partners began its role as the lead book-running manager for an offering on behalf of BlossomHill Therapeutics, Inc. on August 1, 2026.

1 report, 1 independent Updated Aug 1
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Leerink partners began its role as the lead book-running manager for an offering on behalf of BlossomHill Therapeutics, Inc. on August 1, 2026.

Who's involved

What this event is mainly about
Leerink partners

Keep exploring

Part of

LB Pharmaceuticals Inc is seeking institutional investment for a private placement, utilizing Leerink Partners as the placement agent, with BB Biotech as a key entity. All 1 developments

The entities involved

Related events

Coverage

Newest first; wire copies grouped